{"id":"https://openalex.org/W4403772678","doi":"https://doi.org/10.1016/b978-0-443-13466-1.00034-9","title":"Stability studies: General regulatory considerations and regional differences","display_name":"Stability studies: General regulatory considerations and regional differences","publication_year":2024,"publication_date":"2024-10-25","ids":{"openalex":"https://openalex.org/W4403772678","doi":"https://doi.org/10.1016/b978-0-443-13466-1.00034-9"},"language":"en","primary_location":{"id":"doi:10.1016/b978-0-443-13466-1.00034-9","doi":"https://doi.org/10.1016/b978-0-443-13466-1.00034-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-443-13466-1.00034-9","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Specification of Drug Substances and Products","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4403771467","display_name":"Specification of Drug Substances and Products"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029110874","display_name":"Kim Huynh\u2010Ba","orcid":"https://orcid.org/0000-0001-7033-643X","observed_orcids":["https://orcid.org/0000-0001-7033-643X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Huynh-Ba","raw_affiliation_strings":["Pharmalytik LLC, Newark, DE, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmalytik LLC, Newark, DE, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035674898","display_name":"Christopher Latoz","orcid":"https://orcid.org/0000-0003-2813-4150","observed_orcids":["https://orcid.org/0000-0003-2813-4150"]},"institutions":[{"id":"https://openalex.org/I4210162911","display_name":"Hollister (United States)","ror":"https://ror.org/05jvg6713","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162911"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Latoz","raw_affiliation_strings":["Hollister Incorporated, Libertyville, IL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hollister Incorporated, Libertyville, IL, United States","institution_ids":["https://openalex.org/I4210162911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049885081","display_name":"Lori McCaig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori McCaig","raw_affiliation_strings":["Pfizer Inc., South San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., South San Francisco, CA, United States","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6833,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.75249501,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"47","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.7120000123977661},{"id":"https://openalex.org/keywords/stability-testing","display_name":"stability testing","score":0.5849999785423279},{"id":"https://openalex.org/keywords/ich-guidelines","display_name":"ICH guidelines","score":0.8379999995231628},{"id":"https://openalex.org/keywords/regulatory-harmonization","display_name":"regulatory harmonization","score":0.8939999938011169},{"id":"https://openalex.org/keywords/product-specifications","display_name":"product specifications","score":0.5979999899864197},{"id":"https://openalex.org/keywords/world-health-organization","display_name":"World Health Organization","score":0.4740000069141388},{"id":"https://openalex.org/keywords/asean","display_name":"ASEAN","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anvisa","display_name":"ANVISA","score":1.0}],"concepts":[{"id":"https://openalex.org/C112972136","wikidata":"https://www.wikidata.org/wiki/Q7595718","display_name":"Stability (learning theory)","level":2,"score":0.44733956456184387},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2678455710411072},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/b978-0-443-13466-1.00034-9","doi":"https://doi.org/10.1016/b978-0-443-13466-1.00034-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-443-13466-1.00034-9","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Specification of Drug Substances and Products","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5217000246047974,"display_name":"Partnerships for the goals","id":"https://metadata.un.org/sdg/17"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W635912466","https://openalex.org/W1695963280","https://openalex.org/W2045483786","https://openalex.org/W2087920030","https://openalex.org/W2127152151","https://openalex.org/W2166461238","https://openalex.org/W2186154687","https://openalex.org/W2189141330","https://openalex.org/W2199771129","https://openalex.org/W2399644717","https://openalex.org/W2482385581","https://openalex.org/W2548279982","https://openalex.org/W2753362439","https://openalex.org/W2790982185","https://openalex.org/W2796056061","https://openalex.org/W2802776154","https://openalex.org/W2905126078","https://openalex.org/W3017152917","https://openalex.org/W3020578703","https://openalex.org/W3040978681","https://openalex.org/W3167926840","https://openalex.org/W3170993684","https://openalex.org/W3184756831","https://openalex.org/W3214851490","https://openalex.org/W4224238302","https://openalex.org/W4224279559","https://openalex.org/W4224301226","https://openalex.org/W4233259899","https://openalex.org/W4240012645","https://openalex.org/W4319866903","https://openalex.org/W4323350718","https://openalex.org/W4367556523","https://openalex.org/W4375845691","https://openalex.org/W4387108177","https://openalex.org/W4387706500","https://openalex.org/W4388698943","https://openalex.org/W6686821848","https://openalex.org/W6687550494","https://openalex.org/W6796960630"],"related_works":["https://openalex.org/W3042748137","https://openalex.org/W2489493645","https://openalex.org/W3043478594","https://openalex.org/W2964145306","https://openalex.org/W4231610820","https://openalex.org/W2486528993","https://openalex.org/W2999971975","https://openalex.org/W3196867216","https://openalex.org/W1982829395","https://openalex.org/W2261381598"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-10-26T00:00:00"}